glp-1 cardiovascular outcomes 2025 news Risks after Discontinuation GLP-1 trends 2025: real-world data,

Over 23 months, patients notice enhanced exercise capacity, better metabolic markers, and a general sense of vitality that reflects healthier cellular function

The Wegovy pill, taken once daily, is recommended to start at 1.5 mg and increase every 30 days as tolerated until reaching their maintenance dose (maximum 25 mg)

1 For people living with T2D, optimization of glycemic control and cardiovascular (CV) risk factors (e.g., blood pressure, cholesterol, and smoking cessation) are components of standard-of-care management to avoid and/or delay the progression of DM-related complications

Do not use Foundayo if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have a condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)